Form EFFECT Tempest Therapeutics,
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | April 9, 2026 4:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tapestry, Inc. Reports Fiscal 2026 Fourth Quarter and Full Year Results
- Hannan Stavaträsk Maiden Drilling Hits Gold in Every Hole Across 650 m Strike; High-Grade 0.6 m at 27.8 g/t Au and Broader Target of 9.2 m at 1.3 g/t Au Confirm Large-Scale System; IP Geophysics Next
- Animated Feature All Wishes Come True! Hits Australian Screens as Chengdu's Digital Cultural and Creative Industry Steps Up Its Efforts to "Go Global"
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share